The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The Role of Tissue Factor and Factor VIIa in Hemostasis
Open accessAbstract
Tissue factor (TF) is a transmembrane receptor for Factor VII/VIIa (FVII/VIIa). It is constitutively expressed by cells surrounding blood vessels. The endothelium physically separates this potent "activator" from its circulating ligand FVII/FVIIa and prevents inappropriate activation of the clotting cascade. Breakage of the endothelial barrier leads to exposure of extravascular TF and rapid activation of the clotting cascade. TF is also expressed in certain tissues, such as the heart and brain, and provides additional hemostatic protection to these tissues. Small amounts of TF are also present in blood in the form of microparticles, which are small membrane vesicles derived from activated and apoptotic cells. Levels of microparticle TF increase in a variety of diseases, such as sepsis and cancer, and this so-called "blood-borne" TF may contribute to thrombosis associated with these diseases. Recombinant FVIIa has been developed as an effective hemostatic drug for the treatment of hemophilia patients with inhibitory antibodies. In addition, it is used for patients with bleeding that do not respond to conventional therapy. However, the mechanism by which recombinant FVIIa restores hemostasis has not been clearly defined. In conclusion, the TF:FVIIa complex is essential for hemostasis and recombinant FVIIa is an effective hemostatic drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482
The coagulation cascade: initiation, maintenance, and regulation
Davie, E. W., Fujikawa, K., & Kisiel, W. (1991) · Biochemistry · doi:10.1021/bi00107a001 · Cited by 1,808
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707534 · Cited by 1,255 · cited 1×
“Recently, the efficacy and safety of rFVIIa was assessed in patients with acute intracerebral hemorrhage.(44) Unfortunately, despite a reduction in bleeding the low (20 g/kg) and high (80 g/kg) doses of rFVIIa did not improve clinical outcome.”
BackgroundDrake, T. A., Morrissey, J. H., & Edgington, T. S. (1989) · Europe PMC (PubMed Central) · Cited by 1,192
Tissue factor and hemostasis [published erratum appears in Blood 1988 Apr;71(4):1178]
Nemerson, Y. (1988) · Blood · doi:10.1182/blood.v71.1.1.1 · Cited by 682
Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa
O’Connell, K. A. (2006) · JAMA · doi:10.1001/jama.295.3.293 · Cited by 671
Role of tissue factor in embryonic blood vessel development
Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, L., Demunck, H., Kasper, M., Breier, G., Evrard, P., et al. (1996) · Nature · doi:10.1038/383073a0 · Cited by 669
Self-citationRole of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development
Mackman, N. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000130465.23430.74 · Cited by 658
Self-citationStein, B., Baldwin, A. S., Ballard, D. W., Greene, W. C., Angel, P., & Herrlich, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06066.x · Cited by 629
Yu, J. L., May, L., Lhotak, V., Shahrzad, S., Shirasawa, S., Weitz, J. I., Coomber, B. L., Mackman, N., & Rak, J. W. (2005) · Blood · doi:10.1182/blood-2004-05-2042 · Cited by 570
Self-citation
Cited by
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
New Fundamentals in Hemostasis
Versteeg, H. H., Heemskerk, J. W. M., Levi, M., & Reitsma, P. H. (2013) · Physiological Reviews · doi:10.1152/physrev.00016.2011 · Cited by 1,126
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081
Microparticles in Hemostasis and Thrombosis
Owens, A. P., & Mackman, N. (2011) · Circulation Research · doi:10.1161/circresaha.110.233056 · Cited by 835
Self-citationTissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Grover, S. P., & Mackman, N. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309846 · Cited by 667
Self-citationMaegele, M., Schöchl, H., Menovsky, T., Maréchal, H., Marklund, N., Buki, A., & Stanworth, S. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30197-7 · Cited by 356
Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
Hylek, E. M., Held, C., Alexander, J. H., Lopes, R. D., De Caterina, R., Wojdyla, D. M., Huber, K., Jansky, P., Steg, P. G., Hanna, M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.549 · Cited by 344
Coagulation and innate immune responses: can we view them separately?
Delvaeye, M., & Conway, E. M. (2009) · Blood · doi:10.1182/blood-2009-05-199208 · Cited by 315
Treatment of uveal melanoma: where are we now?
Yang, J., Manson, D. K., Marr, B. P., & Carvajal, R. D. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834018757175 · Cited by 300
Advances in the understanding of trauma-induced coagulopathy
Chang, R., Cardenas, J. C., Wade, C. E., & Holcomb, J. B. (2016) · Blood · doi:10.1182/blood-2016-01-636423 · Cited by 287
Mladěnka, P., Macáková, K., Kujovská Krčmová, L., Javorská, L., Mrštná, K., Carazo, A., Protti, M., Remião, F., Nováková, L., & collaborators, T. O. R. A. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab061 · Cited by 262
Thrombotic complications of COVID-19
Avila, J., Long, B., Holladay, D., & Gottlieb, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.065 · Cited by 143
Flaker, G. C., Eikelboom, J. W., Shestakovska, O., Connolly, S. J., Kaatz, S., Budaj, A., Husted, S., Yusuf, S., Lip, G. Y. H., & Hart, R. G. (2012) · Stroke · doi:10.1161/strokeaha.112.664144 · Cited by 94
Holy, E. W., Forestier, M., Richter, E. K., Akhmedov, A., Leiber, F., Camici, G. G., Mocharla, P., Lüscher, T. F., Beer, J. H., & Tanner, F. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226118 · Cited by 88
Metadata
- Authors
- Mackman, N.
- Venue
- Anesthesia & Analgesia
- Published
- 2009-05
- Volume
- 108
- Issue
- 5
- Pages
- 1447-1452
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2058157135
- Cited by
- 335
- References
- 35
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.